[Immunotherapy in the combined treatment of chronic destructive pulmonary tuberculosis].
Ivanova. L A LA
Key Findings
- Thymalin/T‑activin plus prednisolone increased T‑cell counts and activity in chronic TB patients
- The combination led to quicker disappearance of TB bacteria from sputum
- Patients recovered enough to leave the hospital sooner than those on usual treatment
Practical Outcomes
- For most biohackers, this isn’t a directly usable protocol for longevity or performance. It shows these peptides can modulate immunity in serious infections, but the study lacks dosage details, safety data for healthy people, and relevance to non‑TB contexts.
Summary
The study tested a mix of immune‑boosting peptides (thymalin and T‑activin) plus a steroid in people with long‑standing lung TB and found the combo helped their immune cells recover faster and cleared the bacteria sooner than standard care, shortening hospital stays.
Abstract
The paper provides the results of treatment of chronic pulmonary tuberculosis patients by using immunoactive drugs (thymalin and T-activin) and prednisolone, which has been performed by monitoring immunological parameters. The patients with fibrous and cavernous tuberculosis display a combination of antituberculous antibody hyperproduction and specific cell-mediated response inhibition. Immunological hormone therapy allows normalization of the immunological status (an increase in the count and functional activity of T-lymphocytes) and relative stabilization of the process with cessation of bacterial isolation in shorter periods than in the controls, which is favourable to the reduction in hospital treatment periods.
Study Information
pubmed
1994